Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Revises Catalog On Basic Medicine

This article was originally published in PharmAsia News

Executive Summary

China's national catalog of basic medicines is expected to be published this June after its submission to the State Council for approval this April. As the foundation of other domestic medical product listings, the catalog covers almost 500 medicines - in contrast to the usual 300 of overseas medicines - of which some 200 are traditional Chinese medicine that include ethnic and local medications. Officials revealed that a consensus has been reached on pricing of the listed items, which will be strictly regulated. Domestic pharmaceutical companies hope to see a comprehensive strategy that incorporates a more scientific approach to the pricing and tender process for medicine so that they can compete with foreign enterprises dominating the major sales. (Click here for more - Chinese Language)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC068072

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel